Area of research
Hematology · Oncology
Research interest
Research focused on Oncology and Vemurafenib, with related work in Cytokine release syndrome, KRAS, Fludarabine. Notable publications include 'Personalized medicine and pharmacogenetic biomarkers: progress in molecular oncology testing', 'Real-World Outcomes for Patients with Relapsed or Refractory (R/R) Aggressive B-Cell Non-Hodgkin's Lymphoma (aBNHL) Treated with Commercial Tisagenlecleucel: Subgroup Analyses...', and 'Real-world outcomes with tisagenlecleucel in aggressive B-cell lymphoma: subgroup analyses from the CIBMTR registry'.
Real-world outcomes with tisagenlecleucel in aggressive B-cell lymphoma: subgroup analyses from the CIBMTR registry
Real-World Outcomes for Patients with Relapsed or Refractory (R/R) Aggressive B-Cell Non-Hodgkin's Lymphoma (aBNHL) Treated with Commercial Tisagenlecleucel: Subgroup Analyses from the Center for International Blood and Marrow Transplant Research (CIBMTR) Registry
Personalized medicine and pharmacogenetic biomarkers: progress in molecular oncology testing